Identification of phenobarbitone-modulated genes in mouse liver by differential display

Journal of Biochemical and Molecular Toxicology

Volumn 14, Issue 2, 2000, Pages 65-72

  Garcia Allan, Claudia ^a   Lord, Peter G ^a   Loughlin, Johanna M ^a   Orton, Terry C ^a   Sidaway, James E ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

C57B1 10J mouse; Carcinogenesis; Differential display; Gene expression; Liver; Phenobarbitone; Sulphotransferase

Indexed keywords

COMPLEMENTARY DNA; PHENOBARBITAL; SULFOTRANSFERASE;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; LIVER; MALE; METABOLISM; MOUSE; POLYMERASE CHAIN REACTION;

ANIMALS; DNA, COMPLEMENTARY; GENE EXPRESSION; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; PHENOBARBITAL; POLYMERASE CHAIN REACTION; SULFOTRANSFERASES;

EID: 0033630046     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-0461(2000)14:2<65::aid-jbt1>3.0.co;2-%23     Document Type: Article

References (4)

1. Whysner J, Ross P, Williams G. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 1996;71:153-191.
2. Diwan B, Rice J, Ohshima M, Ward J. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/ 2NCr mice. Carcinogenesis 1986;7:215-220.
3. Kolaja K, Stevenson D, Johnson J, Walborg EFJ, Klaunig J. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol 1996;29:219-228.
4. Orton T, Doughty S, Kalinowski A, Lord P, Wadsworth P. Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis 1996;17:973-981.